Business Context and Reporting Period
This Form 8-K was filed by Gemphire Therapeutics Inc. (not Metavia Inc.) on March 20, 2019. The report addresses a regulatory notice received from the Nasdaq Stock Market regarding the company's continued listing status.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it discloses the following critical financial metric:
- Stockholders' Equity: Reported as below $10 million in the Annual Report on Form 10-K for the year ended December 31, 2018.
Material Changes and Listing Status
On March 20, 2019, the Company received written notice from Nasdaq stating it no longer complies with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5450(b)(1)(A) for the Nasdaq Global Market. The Company also does not meet the alternative compliance standards under Rule 5450(b).
Outlook, Risks, and Management Commentary
Compliance Timeline: The Company has 45 calendar days (until May 6, 2019) to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 days to provide evidence of compliance.
Alternative Options: The Company may consider transferring its common stock to the Nasdaq Capital Market, which requires a minimum stockholders' equity of $2.5 million, provided all other listing requirements are met.
Risks and Uncertainties: Management explicitly states there is no assurance that a compliance plan will be timely submitted, accepted by Nasdaq, or that the Company will successfully regain compliance. The filing includes standard forward-looking statement disclaimers regarding these uncertainties.
Investor Verification Checklist
- Verify the exact stockholders' equity figure from the Form 10-K for the year ended December 31, 2018.
- Monitor the submission of a compliance plan to Nasdaq by the May 6, 2019 deadline.
- Assess the feasibility of transferring to the Nasdaq Capital Market versus regaining Global Market status.
- Review the "Risk Factors" section in recent SEC filings for additional details on financial stability.